What is anterolisthesis of the lumbar spine in a 63-year-old female?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is Anterolisthesis of the Lumbar Spine in a 63-Year-Old Female?

Anterolisthesis is the forward slippage of one vertebra relative to the vertebra below it, most commonly occurring at L4-L5 or L5-S1 in the lumbar spine, and in a 63-year-old woman, this is typically degenerative in nature (Wiltse Type III) caused by progressive disc degeneration and facet joint changes.

Definition and Pathophysiology

Anterolisthesis represents anterior displacement of a vertebral body, measured in millimeters or as a percentage of vertebral body width. In your patient's demographic:

  • Degenerative anterolisthesis is the result of progressive intervertebral disc degeneration combined with facet joint arthrosis that leads to sagittalization (reorientation) of the facet joints 1
  • This destabilizes the vertebral segment, allowing anterior translation
  • The condition predominantly affects women with a 5:1 ratio compared to men 1
  • Peak prevalence occurs in the 60-64 age group, where 28.57% of women are affected 2

Prevalence and Location

The epidemiological data for your patient's age group shows:

  • Overall prevalence of anterolisthesis in middle-aged populations ranges from 6.99% to 58.3% depending on the population studied 3, 4, 2
  • L4-L5 is the most commonly affected level, followed by L5-S1 2, 1
  • The slip rarely exceeds 30% (Grade I) in degenerative cases 1
  • Most cases (90%) involve a single vertebral level 3

Clinical Significance

The presence of anterolisthesis does not automatically correlate with symptoms or functional impairment. This is a critical distinction:

  • Anterolisthesis of ≥3mm is not associated with increased back pain or functional disability in most elderly women 3
  • The severity of symptoms does not correlate with the degree of slip 1
  • However, when symptomatic, the cardinal manifestation is lumbar pain with or without radicular symptoms 1
  • Neurogenic claudication occurs in 75% of symptomatic patients, caused by nerve root compression and blood hypoperfusion, manifesting as lower extremity pain with variable walking distances 1

Grading and Measurement

Anterolisthesis is graded by the percentage of vertebral body slippage:

  • Grade I: <25% (95.71% of cases) 2
  • Grade II: 25-50% (4.29% of cases) 2
  • Grade III and IV: Rare in degenerative cases 2

Slippage ≥2mm is considered clinically measurable, though high-grade slip (≥4mm) may be associated with worse neurological recovery if surgical intervention becomes necessary 5.

Diagnostic Approach

For a 63-year-old woman with suspected anterolisthesis, obtain:

  1. Standing lateral lumbar radiographs (essential for weight-bearing assessment)
  2. Flexion-extension views to assess segmental instability (>5mm translation indicates instability) 6
  3. MRI lumbar spine if symptoms are present and surgical candidacy is being considered 7
  4. Measure specific parameters: slip distance in millimeters, disc height, and assess for concomitant stenosis

Management Implications

Conservative treatment is first-line therapy regardless of slip grade 1:

  • Physical therapy focusing on core stabilization
  • Analgesics and anti-inflammatories
  • Activity modification
  • Minimum 6 weeks of conservative management before considering imaging for surgical planning 7

Surgical consideration becomes relevant when:

  • Symptoms persist despite 6 weeks of optimal conservative management 7
  • Concomitant stenosis with spondylolisthesis is present—this combination has strong evidence (Grade B) supporting decompression with fusion 8, 9
  • The SPORT trial provides Level II evidence that surgical patients with stenosis and spondylolisthesis experience superior outcomes at every time point for at least 4 years 9

Key Clinical Pitfall

Do not assume anterolisthesis is the pain generator. Many elderly women have radiographic anterolisthesis without symptoms 3. The decision to attribute symptoms to anterolisthesis requires correlation with clinical presentation, particularly the presence of neurogenic claudication or radiculopathy, and exclusion of other pain sources.

Related Questions

What are the recommended physical therapy exercises for an adult with grade‑1 lumbar anterolisthesis without neurological deficit?
What is a grade 1 anterolisthesis (forward slip) of L3 (third lumbar vertebra) over L5 (fifth lumbar vertebra)?
What is the recommended management for a patient with grade I/II anterolisthesis?
What is the recommended method to trace (detect) anterolisthesis?
What is the significance of a minimal grade 1 anterolisthesis (forward displacement of a vertebra) of Lumbar 4 (L4) on Lumbar 5 (L5) measuring approximately 5 millimeters?
What are the weight‑based dosing recommendations for tranexamic acid in pediatric patients for oral, intravenous, and topical use?
For a post‑menopausal woman using estradiol vaginal cream for digital application, approximately how much volume does a 0.5 g dose represent?
What is the interpretation and recommended work‑up for a patient with macrocytosis (MCV ≈ 106 fL), elevated MCH (≈ 31 pg), low bicarbonate (CO₂ ≈ 31 mmol/L) and a low anion gap (≈ 8 mEq/L)?
Is type 1 diabetes caused by a congenital autoimmune disorder?
What is the significance and recommended work‑up for a white blood cell count of 15,000/µL with lymphocytosis?
What is the optimal latent tuberculosis infection treatment regimen for a healthcare worker who has a positive QuantiFERON‑Gold test, a normal chest X‑ray, and was exposed to a patient with pulmonary tuberculosis that is isoniazid‑resistant based on drug susceptibility testing?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.